Blackstone inks $1.5bn sale of ZO Skin Health to Galderma
Wednesday, October 14, 2026 · first reported by PE Hub and 3 others
Galderma is buying ZO Skin Health from Blackstone for $1.5bn. ZO was founded by dermatologist Zein Obagi. Its net sales came to about $330m for the year ended June, and its range covers over 40 products, marketed in more than 40 countries.
Global Legal Post reports that Ropes advises Galderma, a Swiss skincare group, and that the acquisition raises its exposure to the US market. Weil and Paul Weiss represent ZO and Blackstone.
- Firm
- Blackstone
- Also named
- Galderma, ZO Skin Health
- Deal value
- $1.5B
- Asset class
- Private equity
- Geography
- North America
Advisers Ropes & Gray (legal counsel), Weil (legal counsel), Paul Weiss (legal counsel), Lazard (financial adviser), J.P. Morgan (financial adviser)
In the directory
- Paul, Weiss, Rifkind, Wharton & Garrison · Counsel to the target · fund lawyers at the firm
- Weil, Gotshal & Manges · Counsel to the target · fund lawyers at the firm
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
4 sourcesMore on Blackstone
Everything on this firm →- Blackstone and Warburg Pincus explore $10bn IntraFi salePrivate Equity Wire
- Blackstone’s Foley on the speedy close of a fifth energy transition fundPrivate Equity International +16
- Blackstone hires from M&G to grow Brio platform in EuropePERE
- Blackstone makes marquee hire for new European credit platformGreen Street News
- Rexford Sells $1.3B in SoCal Industrial Assets as Leasing ReboundsCommercial Observer
- Latham Steers 42% Valencia CF Stake Sale To KKR FoundersLaw360
- Deutsche Boerse’s $6 Billion Allfunds Deal Faces EU Decision by Nov. 27pymnts.com
- CVC explores Verisure take-private one year after €13.7bn IPOPrivate Equity Wire +1
- Permira exits Octus in $3.5bn LSEG acquisitionPrivate Equity Wire
- EQT agrees €9.6bn takeover of QiagenPrivate Equity Wire +5